| Literature DB >> 30187429 |
Ewa Laskowska1, Łukasz Sebastian Jarosz2, Zbigniew Grądzki1.
Abstract
The aim of the study was to determine the effect of EM Bokashi® on the phagocytic activity of monocytes and granulocytes, oxidative burst, SWC3, and CD11b + CD18+ expression on monocytes and granulocytes, and the serum concentration of cytokine and lysozyme in pig. 60 Sixty female piglets were divided into two groups: I - control and II - experimental. For the experimental group, a probiotic in the form of the preparation EM Bokashi® was added to the basal feed. Flow cytometry was used to determine selected non-specific immune response parameters, intracellular production of hydrogen peroxide by peripheral granulocytes and monocytes, and surface particles in peripheral blood. The EM Bokashi® preparation used in the study was found to increase phagocytic activity mainly in monocytes, with an increased percentage of phagocytic cells in the experimental group. The highest serum lysozyme concentration in the piglets in the experimental group (2.89 mg/dl), was noted on day 42 of the study. In the group of pigs receiving EM Bokashi®, the percentage of phagocytic cells with SWC3 (monocyte/granulocyte) expression was statistically significantly higher than in the control. The increase in the number of cells with SWC3 (monocyte/granulocyte) expression in the peripheral circulation in combination with the greater capacity of the cells for phagocytosis and respiratory burst confirms that the non-specific immune response was modulated in the pigs supplemented with EM Bokashi®.Entities:
Keywords: Cytokine; Lysozyme; Multimicrobial probiotic preparation; Oxidative burst; Phagocytic activity; Pigs
Mesh:
Year: 2019 PMID: 30187429 PMCID: PMC6853859 DOI: 10.1007/s12602-018-9460-5
Source DB: PubMed Journal: Probiotics Antimicrob Proteins ISSN: 1867-1306 Impact factor: 4.609
Ingredients and nutritive value of the pigs diets (as-fed basis)
| Ingredient (g) | Startera≥ 12 kg | Grower 12–30 kg | Finisher 30–110/115 kg |
|---|---|---|---|
| Barley | – | 37.0 | 39.5 |
| Wheat | – | 39.5 | 39.0 |
| Corn/gelatinized corn | 41.0/3.2 | – | – |
| Soybean meal over 46% HP | 35.0 | 10.0 | 14.0 |
| Fermented rapeseed meal | – | 2.0 | 4.0 |
| Fermented soybean meal | 2.0 | 2.0 | 2.5 |
| Soybean oil | 15.0 | 2.0 | 1.0 |
| Starch | 1.8–2.0 | – | – |
| Complementary feed 4% MPU START 820115 | 2.0 | 4.00 | – |
| Concentrate MHP | – | 3.0 | – |
| Propionic acid | – | 0.5 | – |
| Bicalcium phosphate/limestone | 0.46/0.30 | – | – |
| Vitamin/mineral suplement | 0.1/0.33 | – | – |
| L-lysine HCL 78%/DL-methionine 98% | 0.076/0.09 | – | – |
| Nutritive value | |||
| Metabolizable energy, MJ/kg | 13.9 | 13.3 | 13.5 |
| Crude protein, g | 201 | 178 | 174 |
| Dry matter, g | – | 827 | 850 |
| Lysine, g | 15.45 | 12.3 | 10 > 3 |
| Methionine,g | 3.72 | 4.47 | 3.06 |
| Methionine + cystine, g | 6.56 | 8.15 | 6.48 |
| Threonine, g | 7.35 | 7.74 | 6.54 |
| Tryptophan, g | 2.22 | 1.95 | 1.99 |
| Digestible lysine, g | 12.29 | 1.70 | 3.22 |
| Total phosphorus, g | 4.52 | 5.25 | 6.01 |
| Digestible phosphorus, g | – | 4.28 | 3.74 |
| Calcium, g | 8.26 | 8.27 | 6.49 |
| Sodium, g | – | 2.33 | 1.67 |
| Fiber, g | 36.0 | 36.1 | 40.0 |
| Raw fat, g | – | 39.3 | 28.6 |
| Vitamin A, IU | – | 16,000.0 | 10,500.0 |
| Vitamin D3, IU | – | 2000.0 | 2000.0 |
| Vitamin E, mg | – | 115 | 115 |
aCommercial product without probiotic, data in the table provided by the manufacturer
Effect of the use of effective microorganisms on pig health
| Day of life | Group I | Group II |
|---|---|---|
| 0 | – | – |
| 7 | Cough | – |
| 14 | Diarrhea | Diarrhea |
| Decreased appetite | Decreased appetite | |
| 21 | – | – |
| 28 | Diarrhea | Diarrhea |
| Sneezing | Sneezing | |
| Decreased appetite | Decreased appetite | |
| 35 | Diarrhea | Cough |
| Cough | Sneezing | |
| Sneezing | ||
| Decreased appetite | ||
| 42 | Cough | – |
| Sneezing | ||
| 63 | Diarrhea | – |
| Cough | ||
| Sneezing | ||
| Decreased appetite | ||
| 70 | Cough | Cough |
| 98 | – | – |
| 126 | – | – |
| 154 | – | – |
Fig. 1Percentage of subpopulation SWC3 (monocyte/granulocyte)-I and CD11b+CD18+-II in the peripheral blood of pigs from groups I and II. I-control group, II-experimental group. Values are expressed as the mean and standard deviation (α+/-SD). Asterisks indicate a significant increase in the parameter (*p < 0.05) between control and experimental group
Fig. 2Assessment of phagocytosis: I–percentage (%) of total phagocytic cells, II–percentage (%) of phagocytic cells–granulocytes, III–percentage (%) of phagocytic cells–monocytes in pigs. I–control group, II-experimental group. Values are expressed as the mean and standard deviation (α+/-SD). Asterisks indicate a significant increase in the parameter (*p < 0.05) between control and experimental group
Mean fluorescence intensity of peripheral blood phagocytic cells of pigs from groups I and II. Values are expressed as the mean and standard deviation (α+/-SD)
| Day | Mean fluorescence intensity in granulocytes | Mean fluorescence intensity in monocytes | ||
|---|---|---|---|---|
| Group I | Group II | Group I | Group II | |
| 0 | 518.10 ± 92.1 | 543.60 ± 89.7 | 211.77 ± 74.1 | 222.91 ± 83.7 |
| 7 | 479.80 ± 95.4 | 422.80 ± 101.5 | 238.16 ± 72.4 | 234.71 ± 63.1 |
| 14 | 521.16 ± 112.8 | 495.63 ± 105.3 | 233.62 ± 52.1 | 241.12 ± 62.8 |
| 21 | 357.40 ± 101.2 | 481.14 ± 93.5a | 218.20 ± 64.5 | 221.82 ± 59.4 |
| 28 | 397.11 ± 95.4 | 498.55 ± 99.7a | 255.68 ± 73.1 | 295.44 ± 48.9a |
| 35 | 412.17 ± 110.8 | 511.22 ± 101.3a | 261.15 ± 68.7 | 302.16 ± 98.5a |
| 42 | 435.11 ± 99.4 | 516.84 ± 86.4a | 268.22 ± 57.3 | 311.18 ± 84.3a |
| 63 | 520.19 ± 121.3 | 744.31 ± 124.88a | 318.14 ± 62.1 | 378.42 ± 58.6a |
| 70 | 684.22 ± 117.3a | 521.15 ± 119.1 | 351.22 ± 63.5 | 392.19 ± 54.2a |
| 98 | 621.11 ± 108.7a | 477.25 ± 103.2 | 372.14 ± 74.8 | 403.15 ± 61.3a |
| 126 | 576.52 ± 111.4a | 492.11 ± 95.1 | 377.81 ± 69.7 | 384.12 ± 72.1 |
| 154 | 493.28 ± 79.7 | 471.84 ± 84.2 | 315.69 ± 73.2 | 325.11 ± 49.7 |
aAsterisks indicate a significant increase in the parameter (*p < 0.05) between control and experimental group. I-control group, II-experimental group
Granulocyte and monocyte oxidative burst under E. coli stimuli of pigs from groups I and II. Values are expressed as the mean and standard deviation (α+/-SD)
| Day | Oxidized cells (%) | |
|---|---|---|
| Group I | Group II | |
| 0 | 48.6 ± 5.3 | 47.7 ± 6.8 |
| 7 | 45.1 ± 7.2 | 46.6 ± 5.8 |
| 14 | 46.1 ± 6.3 | 49.8 ± 7.1 |
| 21 | 59.6 ± 9.2 | 65.4 ± 9.2a |
| 28 | 64.5 ± 8.1 | 76.8 ± 10.1a |
| 35 | 72.6 ± 9.5 | 89.4 ± 11.3a |
| 42 | 64.3 ± 10.2 | 78.5 ± 8.7a |
| 63 | 56.8 ± 9.1 | 76.6 ± 7.2a |
| 70 | 62.4 ± 11.2 | 71.2 ± 6.5a |
| 98 | 73.4 ± 12.3 | 72.6 ± 11.4 |
| 126 | 79.5 ± 10.8 | 75.8 ± 10.2 |
| 154 | 56.7 ± 9.7 | 69.7 ± 8.2a |
aAsterisks indicate a significant increase in the parameter (*p < 0.05) between control and experimental group. I-control group, II-experimental group
Fig. 3Lysozyme concentration (mg/l) in the peripheral blood of pigs from groups I and II. I–control group, II-experimental group. Values are expressed as the mean and standard deviation (α+/-SD). Asterisks indicate a significant increase in the parameter (*p < 0.05) between control and experimental group
Serum concentrations of IL-6, IL-10, and TNF-α in pigs from groups I and II. Values are expressed as the mean and standard deviation (α+/-SD)
| IL-6 | TNF-α | IL-10 | ||||
|---|---|---|---|---|---|---|
| Day | I | II | I | II | I | II |
| 0 | 10.82 ± 5.43 | 10.12 ± 6.11 | – | – | 10.14 ± 6.12 | 9.06 ± 4.21 |
| 7 | 20.28 ± 8.25 | 21.11 ± 12.73 | 28.14 ± 11.55 | 26.18 ± 9.27 | 15.21 ± 7.12 | 16.12 ± 8.73 |
| 14 | 28.34 ± 10.21 | 27.62 ± 11.89 | 30.21 ± 17.23 | 31.11 ± 12.39 | 18.33 ± 7.82 | 19.05 ± 10.22 |
| 21 | 38.16 ± 12.87 | 39.41 ± 16.59 | 33.16 ± 18.22 | 35.82 ± 11.72 | 29.64 ± 10.11 | 31.82 ± 7.99 |
| 28 | 80.62 ± 18.65 | 81.89 ± 15.94 | 37.98 ± 9.91 | 36.98 ± 9.89 | 45.75 ± 14.95 | 45.65 ± 15.25 |
| 35 | 87.25 ± 19.23 | 86.84 ± 19.22 | 39.21 ± 11.12 | 59.64 ± 10.81a | 46.22 ± 11.25 | 52.11 ± 12.38 |
| 42 | 96.37 ± 21.84 | 93.28 ± 21.33 | 45.54 ± 10.95 | 87.87 ± 25.53a | 45.53 ± 18.29 | 58.59 ± 11.25a |
| 63 | 105.84 ± 17.25 | 127.83 ± 19.27a | 43.11 ± 9.72 | 94.25 ± 10.08a | 36.24 ± 12.79 | 69.27 ± 16.31a |
| 70 | 139.57 ± 24.71 | 148.75 ± 28.06a | 40.90 ± 12.35 | 97.94 ± 21.76a | 38.64 ± 9.28 | 76.02 ± 11.89a |
| 98 | 111.42 ± 22.11 | 152.84 ± 21.63a | 47.28 ± 7.56 | 105.21 ± 12.86a | 39.92 ± 11.73 | 81.14 ± 15.22a |
| 126 | 108.70 ± 16.63 | 164.20 ± 23.39a | 57.78 ± 9.34 | 111.31 ± 14.04a | 40.47 ± 14.23 | 89.39 ± 12.74a |
| 154 | 151.14 ± 26.44 | 248.26 ± 30.43a | 87.28 ± 10.21 | 135.70 ± 16.55a | 38.76 ± 16.21 | 79.83 ± 10.95a |
aAsterisks indicate a significant increase in the parameter (*p < 0.05) between control and experimental group. I-control group, II-experimental group